Literature DB >> 27236789

Synthetic mRNA: Production, Introduction into Cells, and Physiological Consequences.

Robert E Rhoads1.   

Abstract

Recent advances have made it possible to synthesize mRNA in vitro that is relatively stable when introduced into mammalian cells, has a diminished ability to activate the innate immune response against exogenous (virus-like) RNA, and can be efficiently translated into protein. Synthetic methods have also been developed to produce mRNA with unique investigational properties such as photo-cross-linking, fluorescence emission, and attachment of ligands through click chemistry. Synthetic mRNA has been proven effective in numerous applications beneficial for human health such as immunizing patients against cancer and infections diseases, alleviating diseases by restoring deficient proteins, converting somatic cells to pluripotent stem cells to use in regenerative medicine therapies, and engineering the genome by making specific alterations in DNA. This introductory chapter provides background information relevant to the following 20 chapters of this volume that present protocols for these applications of synthetic mRNA.

Entities:  

Keywords:  Cap analogs; Cationic lipids; Electroporation; Immunotherapy; Innate immunity; Nucleoporation; Poly(A); Protein expression; Translational efficiency; mRNA stability

Mesh:

Substances:

Year:  2016        PMID: 27236789     DOI: 10.1007/978-1-4939-3625-0_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Modified ARCA analogs providing enhanced translational properties of capped mRNAs.

Authors:  Ilona Kocmik; Karolina Piecyk; Magdalena Rudzinska; Anna Niedzwiecka; Edward Darzynkiewicz; Renata Grzela; Marzena Jankowska-Anyszka
Journal:  Cell Cycle       Date:  2018-08-17       Impact factor: 4.534

2.  Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA.

Authors:  Jian Xu; Zhihua Yang; Rui Wang; Fumei He; Rong Yan; Yidi Zhang; Liying Yu; Wenbin Deng; Yichu Nie
Journal:  Commun Biol       Date:  2022-10-14

Review 3.  Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma.

Authors:  Xiangjun Tang; Shenqi Zhang; Rui Fu; Li Zhang; Kuanming Huang; Hao Peng; Longjun Dai; Qianxue Chen
Journal:  Front Oncol       Date:  2019-11-08       Impact factor: 6.244

Review 4.  Current status of research on exosomes in general, and for the diagnosis and treatment of kidney cancer in particular.

Authors:  Weipu Mao; Keyi Wang; Zonglin Wu; Bin Xu; Ming Chen
Journal:  J Exp Clin Cancer Res       Date:  2021-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.